SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gamma Biologicals
GBL 14.78-39.3%Jun 12 9:40 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: A. Reader who wrote (39)4/2/1998 3:59:00 PM
From: A. Reader  Read Replies (1) of 44
 
Gamma Biologicals Expands ReACT Test System Sales by Naming Exclusive Distributor in Canada: Contract Covers New Territory for Gamma
HOUSTON--(BUSINESS WIRE)-- April 1, 1998--With the premarketing phase of the Gamma-ReACT(tm) Test System complete, Gamma Biologicals Inc. (Amex:GBL - news) has named an exclusive distributor in Canada for this patented microcolumn gel technology designed for the rapid and labor-saving detection of red blood cell antibodies. Dominion Biologicals Ltd., of Nova Scotia will hold exclusive rights to market ReACT and certain specialty products throughout Canada for an initial period of five years...
biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext